References analysis of the Wikipedia article "Dimethyltryptamin" in the German version

doi.org

Qu, Shi-Jin; Tan, Chang-Heng; Zhu, Da-Yuan; Wang, Gui-Feng; Zuo, Jian-Ping; Duan, Wen-Hu; Yao, Shan-Yan: Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. In: Bioorganic & Medicinal Chemistry 19 (2011) 3120–3127, doi:10.1016/j.bmc.2011.04.004.

R. Bergin, D. Carlström, G. Falkenberg, H. Ringertz: Preliminary X-ray crystallographic study of some psychoactive indole bases in Acta Cryst. B 24 (1968) 882, doi:10.1107/S0567740868003353.

DMT Models the Near-Death Experience. Front. Psychol., 15. August 2018, abgerufen am 1. September 2018. DOI:10.3389/fpsyg.2018.01424

Smith RL, Canton H, Barrett RJ, Sanders-Bush E: Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. In: Pharmacol. Biochem. Behav. 61. Jahrgang, Nr. 3, November 1998, S. 323–30, doi:10.1016/S0091-3057(98)00110-5, PMID 9768567.

Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H. et al.: Predicting new molecular targets for known drugs. In: Nature. 462. Jahrgang, Nr. 7270, November 2009, S. 175–81, doi:10.1038/nature08506, PMID 19881490, PMC 2784146 (freier Volltext).

Deliganis A.V., Pierce P.A., Peroutka S.J.: Differential interactions of dimethyltryptamine (DMT) with 5-HT_1A and 5-HT₂ receptors. In: Biochemical Pharmacology. 41. Jahrgang, Nr. 11, Juni 1991, S. 1739–44, doi:10.1016/0006-2952(91)90178-8, PMID 1828347.

Pierce P.A., Peroutka S.J.: Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. In: Psychopharmacology. 97. Jahrgang, Nr. 1, 1989, S. 118–22, doi:10.1007/BF00443425, PMID 2540505.

Smith R.L., Canton H., Barrett R.J., Sanders-Bush E.: Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT_2A and 5-HT_2C receptors. In: Pharmacology, Biochemistry and Behavior. 61. Jahrgang, Nr. 3, November 1998, S. 323–30, doi:10.1016/S0091-3057(98)00110-5, PMID 9768567.

T. S. Ray: Psychedelics and the human receptorome. In: PloS one. Band 5, Nummer 2, 2010, S. e9019, doi:10.1371/journal.pone.0009019. PMID 20126400, PMC 2814854 (freier Volltext).

Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E.: The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator. In: Science. 323. Jahrgang, Nr. 5916, Februar 2009, S. 934–7, doi:10.1126/science.1166127, PMID 19213917, PMC 2947205 (freier Volltext).

Su T.P., Hayashi T., Vaupel D.B.: When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor. In: Science Signaling. 2. Jahrgang, Nr. 61, 2009, S. pe12, doi:10.1126/scisignal.261pe12, PMID 19278957, PMC 3155724 (freier Volltext).

Jon G. Dean, Tiecheng Liu, Sean Huff, Ben Sheler, Steven A. Barker: Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain. In: Scientific Reports. Band 9, Nr. 1, 27. Juni 2019, S. 9333, doi:10.1038/s41598-019-45812-w.

D. E. Nichols: Hallucinogens. In: Pharmacology & Therapeutics. Band 101, Nummer 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703.

José M. Capriles, Christine Moore, Juan Albarracin-Jordan, Melanie J. Miller: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. In: Proceedings of the National Academy of Sciences. 1. Mai 2019, S. 201902174, doi:10.1073/pnas.1902174116, PMID 31061128.

Dennis J. McKenna, G.H.N. Towers et al.: Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca. In: Journal of Ethnopharmacology. 10, 1984, S. 195–223, doi:10.1016/0378-8741(84)90003-5.

Barker S.A., Monti J.A., Christian S.T.: N, N-dimethyltryptamine: an endogenous hallucinogen. In: International Review of Neurobiology. 22. Jahrgang, 1981, S. 83–110, doi:10.1016/S0074-7742(08)60291-3, PMID 6792104.

Wallach J.V.: Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. In: Medical Hypotheses. 72. Jahrgang, Nr. 1, Januar 2009, S. 91–4, doi:10.1016/j.mehy.2008.07.052, PMID 18805646.

M. A. Thompson: Rabbit Lung Indolethylamine N-Methyltransferase. cDNA AND GENE CLONING AND CHARACTERIZATION. In: Journal of Biological Chemistry. 273, S. 34502–34510, doi:10.1074/jbc.273.51.34502.

Steven A. Barker, Ethan H. McIlhenny, Rick Strassman: A critical review of reports of endogenous psychedelic N,N-dimethyltryptamines in humans: 1955-2010. In: Drug Testing and Analysis. 4, 2012, S. 617–635, doi:10.1002/dta.422.

Jimo Borjigin, Michael M. Wang, Rick J. Strassman, Steven A. Barker, Ben Sheler: Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain. In: Scientific Reports. Band 9, Nr. 1, 27. Juni 2019, S. 9333, doi:10.1038/s41598-019-45812-w.

nih.gov

ncbi.nlm.nih.gov

T. S. Ray: Psychedelics and the human receptorome. In: PloS one. Band 5, Nummer 2, 2010, S. e9019, doi:10.1371/journal.pone.0009019. PMID 20126400, PMC 2814854 (freier Volltext).

D. E. Nichols: Hallucinogens. In: Pharmacology & Therapeutics. Band 101, Nummer 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703.

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

Dimethyltryptamin (German Wikipedia)

berkeley.edu

news.berkeley.edu

checkit.wien

doi.org

frontiersin.org

globalnews.ca

jstor.org

nih.gov

ncbi.nlm.nih.gov

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

sciencedaily.com

sigmaaldrich.com

thedrugclassroom.com

tocris.com